Insulin resistance, hyperglycemia, and atherosclerosis

Cell Metabolism

Volumn 14, Issue 5, 2011, Pages 575-585

  Bornfeldt, Karin E ^a   Tabas, Ira ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; APOLIPOPROTEIN B; CHOLESTEROL; CYTOKINE; ENDOTHELIN 1; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 1; HEMOGLOBIN A1C; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA ANTIBODY; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; RUBOXISTAURIN; SOMATOMEDIN C RECEPTOR; SORBITOL; TRANSCRIPTION FACTOR FKHR; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTERY ENDOTHELIUM; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC LESIONAL CELL; ATHEROSCLEROTIC PLAQUE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FATALITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOGEN SYNTHESIS; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; SMOOTH MUSCLE FIBER; STROKE;

ANIMALS; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, INSULIN; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 80455128548     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.07.015     Document Type: Review

References (93)

1. N. Adhikari, D.L. Basi, M. Carlson, A. Mariash, Z. Hong, U. Lehman, S. Mullegama, E.K. Weir, and J.L. Hall Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury Arterioscler. Thromb. Vasc. Biol. 31 2011 86 94
2. D. Allard, N. Figg, M.R. Bennett, and T.D. Littlewood Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3 J. Biol. Chem. 283 2008 19739 19747
3. V. Azcutia, M. Abu-Taha, T. Romacho, M. Vázquez-Bella, N. Matesanz, F.W. Luscinskas, L. Rodríguez-Mañas, M.J. Sanz, C.F. Sánchez-Ferrer, and C. Peiró Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo PLoS ONE 5 2010 e10091
4. V. Azcutia, M. Abu-Taha, T. Romacho, M. Vázquez-Bella, N. Matesanz, F.W. Luscinskas, L. Rodríguez-Mañas, M.J. Sanz, C.F. Sánchez-Ferrer, and C. Peiró Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo PLoS ONE 5 2010 e10091
5. S. Bacci, S. Rizza, S. Prudente, B. Spoto, C. Powers, A. Facciorusso, A. Pacilli, D. Lauro, A. Testa, and Y.Y. Zhang The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients Diabetes 60 2011 1000 1007
6. J. Baumgartl, S. Baudler, M. Scherner, V. Babaev, L. Makowski, J. Suttles, M. McDuffie, K. Tobe, T. Kadowaki, and S. Fazio Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis Cell Metab. 3 2006 247 256
7. A. Behn, and E. Ur The obesity epidemic and its cardiovascular consequences Curr. Opin. Cardiol. 21 2006 353 360 (Pubitemid 44315069)
8. S.J. Bensinger, and P. Tontonoz Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 454 2008 470 477
9. G. Boden, and G.I. Shulman Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction Eur. J. Clin. Invest. 32 Suppl 3 2002 14 23 (Pubitemid 41704996)
10. G. Booth, T.J. Stalker, A.M. Lefer, and R. Scalia Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo Diabetes 51 2002 1556 1564 (Pubitemid 34826625)
11. N.M. Borradaile, X. Han, J.D. Harp, S.E. Gale, D.S. Ory, and J.E. Schaffer Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death J. Lipid Res. 47 2006 2726 2737 (Pubitemid 44936086)
12. J. Boucher, Y.H. Tseng, and C.R. Kahn Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription J. Biol. Chem. 285 2010 17235 17245
13. E.M. Bradshaw, K. Raddassi, W. Elyaman, T. Orban, P.A. Gottlieb, S.C. Kent, and D.A. Hafler Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells J. Immunol. 183 2009 4432 4439
14. M.S. Brown, and J.L. Goldstein Selective versus total insulin resistance: a pathogenic paradox Cell Metab. 7 2008 95 96 (Pubitemid 351168559)
15. A. Brown, L.R. Reynolds, and D. Bruemmer Intensive glycemic control and cardiovascular disease: an update Nat. Rev. Cardiol. 7 2010 369 375
16. D.X. Bu, V. Rai, X. Shen, R. Rosario, Y. Lu, V. D'Agati, S.F. Yan, R.A. Friedman, E. Nuglozeh, and A.M. Schmidt Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice Circ. Res. 106 2010 1040 1051
17. A.P. Burke, F.D. Kolodgie, A. Zieske, D.R. Fowler, D.K. Weber, P.J. Varghese, A. Farb, and R. Virmani Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler. Thromb. Vasc. Biol. 24 2004 1266 1271 (Pubitemid 38880019)
18. A.D. Callow Cardiovascular disease 2005 - the global picture Vascul. Pharmacol. 45 2006 302 307 (Pubitemid 44765292)
19. J.M. Chan, L. Zhang, R. Tong, D. Ghosh, W. Gao, G. Liao, K.P. Yuet, D. Gray, J.W. Rhee, and J. Cheng Spatiotemporal controlled delivery of nanoparticles to injured vasculature Proc. Natl. Acad. Sci. USA 107 2010 2213 2218
20. M. Davidson, P.M. Meyer, S. Haffner, S. Feinstein, R. D'Agostino Sr., G.T. Kondos, A. Perez, Z. Chen, and T. Mazzone Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus Circulation 117 2008 2123 2130 (Pubitemid 351572171)
21. R.A. DeFronzo Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 Diabetologia 53 2010 1270 1287
22. S. Devaraj, P. Tobias, and I. Jialal Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes Cytokine 55 2011 441 445
23. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, I.K. Moules, A.M. Skene, M.H. Tan, P.J. Lefbvre, G.D. Murray PROactive investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
24. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, R.G. Roeder, M.E. Cooper, and M. Brownlee Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J. Exp. Med. 205 2008 2409 2417
25. N. Engberding, A. San Martín, A. Martin-Garrido, M. Koga, L. Pounkova, E. Lyons, B. Lassgue, and K.K. Griendling Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 29 2009 408 415
26. E. Erbay, V.R. Babaev, J.R. Mayers, L. Makowski, K.N. Charles, M.E. Snitow, S. Fazio, M.M. Wiest, S.M. Watkins, M.F. Linton, and G.S. Hotamisligil Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nat. Med. 15 2009 1383 1391
27. C. Fernández-Hernando, E. Ackah, J. Yu, Y. Suárez, T. Murata, Y. Iwakiri, J. Prendergast, R.Q. Miao, M.J. Birnbaum, and W.C. Sessa Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease Cell Metab. 6 2007 446 457 (Pubitemid 350163050)
28. C. Fernández-Hernando, L. József, D. Jenkins, A. Di Lorenzo, and W.C. Sessa Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis Arterioscler. Thromb. Vasc. Biol. 29 2009 2033 2040
29. D.A. Fryburg, and M.T. Vassileva Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response Sci. Transl. Med. 3 2011 72cm6
30. P. Geraldes, and G.L. King Activation of protein kinase C isoforms and its impact on diabetic complications Circ. Res. 106 2010 1319 1331
31. R.G. Gerrity, R. Natarajan, J.L. Nadler, and T. Kimsey Diabetes-induced accelerated atherosclerosis in swine Diabetes 50 2001 1654 1665 (Pubitemid 33639607)
32. H.C. Gerstein, M.E. Miller, S. Genuth, F. Ismail-Beigi, J.B. Buse, D.C. Goff Jr., J.L. Probstfield, W.C. Cushman, H.N. Ginsberg, J.T. Bigger ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N. Engl. J. Med. 364 2011 818 828
33. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
34. S. Han, C.P. Liang, T. DeVries-Seimon, M. Ranalletta, C.L. Welch, K. Collins-Fletcher, D. Accili, I. Tabas, and A.R. Tall Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions Cell Metab. 3 2006 257 266
35. E. Harja, D.X. Bu, B.I. Hudson, J.S. Chang, X. Shen, K. Hallam, A.Z. Kalea, Y. Lu, R.H. Rosario, and S. Oruganti Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice J. Clin. Invest. 118 2008 183 194
36. E. Harja, J.S. Chang, Y. Lu, M. Leitges, Y.S. Zou, A.M. Schmidt, and S.F. Yan Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis FASEB J. 23 2009 1081 1091
37. R.R. Henry Glucose control and insulin resistance in non-insulin- dependent diabetes mellitus Ann. Intern. Med. 124 1996 97 103 (Pubitemid 26011604)
38. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 2008 1577 1589
39. Z.Y. Jiang, Y.W. Lin, A. Clemont, E.P. Feener, K.D. Hein, M. Igarashi, T. Yamauchi, M.F. White, and G.L. King Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats J. Clin. Invest. 104 1999 447 457 (Pubitemid 29534329)
40. G.S. Johansson, and H.J. Arnqvist Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells Am. J. Physiol. Endocrinol. Metab. 291 2006 E1124 E1130
41. F. Johansson, F. Kramer, S. Barnhart, J.E. Kanter, T. Vaisar, R.D. Merrill, L. Geng, K. Oka, L. Chan, and A. Chait Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice Proc. Natl. Acad. Sci. USA 105 2008 2082 2087 (Pubitemid 351439468)
42. N. Kaiser, S. Sasson, E.P. Feener, N. Boukobza-Vardi, S. Higashi, D.E. Moller, S. Davidheiser, R.J. Przybylski, and G.L. King Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells Diabetes 42 1993 80 89 (Pubitemid 23013798)
43. J.E. Kanter, F. Johansson, R.C. LeBoeuf, and K.E. Bornfeldt Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ. Res. 100 2007 769 781 (Pubitemid 46555682)
44. Y. Kido, J. Nakae, and D. Accili Clinical review 125: The insulin receptor and its cellular targets J. Clin. Endocrinol. Metab. 86 2001 972 979 (Pubitemid 32322967)
45. V.V. Kunjathoor, D.L. Wilson, and R.C. LeBoeuf Increased atherosclerosis in streptozotocin-induced diabetic mice J. Clin. Invest. 97 1996 1767 1773 (Pubitemid 26105486)
46. P. Lewis, N. Stefanovic, J. Pete, A.C. Calkin, S. Giunti, V. Thallas-Bonke, K.A. Jandeleit-Dahm, T.J. Allen, I. Kola, M.E. Cooper, and J.B. de Haan Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice Circulation 115 2007 2178 2187 (Pubitemid 46659070)
47. S. Li, Y. Sun, C.P. Liang, E.B. Thorp, S. Han, A.W. Jehle, V. Saraswathi, B. Pridgen, J.E. Kanter, and R. Li Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet Circ. Res. 105 2009 1072 1082
48. C.P. Liang, S. Han, H. Okamoto, R. Carnemolla, I. Tabas, D. Accili, and A.R. Tall Increased CD36 protein as a response to defective insulin signaling in macrophages J. Clin. Invest. 113 2004 764 773 (Pubitemid 38544170)
49. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
50. D.J. Lightell Jr., S.C. Moss, and T.C. Woods Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation Endocrinology 152 2011 651 658
51. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
52. J.P. Mauldin, M.H. Nagelin, A.J. Wojcik, S. Srinivasan, M.D. Skaflen, C.R. Ayers, C.A. McNamara, and C.C. Hedrick Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus Circulation 117 2008 2785 2792 (Pubitemid 351770459)
53. T. Mazzone Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data Circulation 122 2010 2201 2211
54. C.S. McAlpine, A.J. Bowes, and G.H. Werstuck Diabetes, hyperglycemia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling Cardiovasc. Hematol. Disord. Drug Targets 10 2010 151 157
55. U. Milman, S. Blum, C. Shapira, D. Aronson, R. Miller-Lotan, Y. Anbinder, J. Alshiek, L. Bennett, M. Kostenko, and M. Landau Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial Arterioscler. Thromb. Vasc. Biol. 28 2008 341 347 (Pubitemid 351161209)
56. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
57. O. Morel, L. Kessler, P. Ohlmann, and P. Bareiss Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis Atherosclerosis 212 2010 367 376
58. S. Morris-Rosenfeld, E. Blessing, M.R. Preusch, C. Albrecht, A. Bierhaus, M. Andrassy, P.P. Nawroth, M.E. Rosenfeld, H.A. Katus, and F. Bea Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression Eur. J. Clin. Invest. 41 2011 1164 1171
59. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin, B. Zinman Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N. Engl. J. Med. 353 2005 2643 2653 (Pubitemid 41817713)
60. M. Ogata, M. Tsujita, M.A. Hossain, N. Akita, F.J. Gonzalez, B. Staels, S. Suzuki, T. Fukutomi, G. Kimura, and S. Yokoyama On the mechanism for PPAR agonists to enhance ABCA1 gene expression Atherosclerosis 205 2009 413 419
61. J.A. Olivares-Reyes, A. Arellano-Plancarte, and J.R. Castillo-Hernandez Angiotensin II and the development of insulin resistance: implications for diabetes Mol. Cell. Endocrinol. 302 2009 128 139
62. U. Ozcan, Q. Cao, E. Yilmaz, A.H. Lee, N.N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Görgün, L.H. Glimcher, and G.S. Hotamisligil Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461 (Pubitemid 39372439)
63. S. Parathath, L. Grauer, L.S. Huang, M. Sanson, E. Distel, I.J. Goldberg, and E.A. Fisher Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice Diabetes 60 2011 1759 1769
64. L. Park, K.G. Raman, K.J. Lee, Y. Lu, L.J. Ferran Jr., W.S. Chow, D. Stern, and A.M. Schmidt Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat. Med. 4 1998 1025 1031 (Pubitemid 28417334)
65. C. Rask-Madsen, Q. Li, B. Freund, D. Feather, R. Abramov, I.H. Wu, K. Chen, J. Yamamoto-Hiraoka, J. Goldenbogen, and K.B. Sotiropoulos Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice Cell Metab. 11 2010 379 389
66. P. Reaven, S. Merat, F. Casanada, M. Sutphin, and W. Palinski Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 17 1997 2250 2256 (Pubitemid 28057129)
67. C.B. Renard, F. Kramer, F. Johansson, N. Lamharzi, L.R. Tannock, M.G. von Herrath, A. Chait, and K.E. Bornfeldt Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions J. Clin. Invest. 114 2004 659 668 (Pubitemid 39578756)
68. C.A. Schuyler, N.N. Ta, Y. Li, M.F. Lopes-Virella, and Y. Huang Insulin Treatment Attenuates Diabetes-Increased Atherosclerotic Intimal Lesions and Matrix Metalloproteinase-9 Expression in Apolipoprotein E-Deficient Mice J. Endocrinol. 210 2011 37 46
69. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, and S. Tsimikas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
70. T. Senokuchi, C.P. Liang, T.A. Seimon, S. Han, M. Matsumoto, A.S. Banks, J.H. Paik, R.A. DePinho, D. Accili, I. Tabas, and A.R. Tall Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress Diabetes 57 2008 2967 2976
71. S.Y. Shai, S. Sukhanov, Y. Higashi, C. Vaughn, J. Kelly, and P. Delafontaine Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability Arterioscler. Thromb. Vasc. Biol. 30 2010 1916 1924
72. 1(C) levels via glycemic and nonglycemic pathways Diabetes 59 2010 3229 3239
73. A. Soro-Paavonen, A.M. Watson, J. Li, K. Paavonen, A. Koitka, A.C. Calkin, D. Barit, M.T. Coughlan, B.G. Drew, and G.I. Lancaster Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461 2469
74. S. Srivastava, E. Vladykovskaya, O.A. Barski, M. Spite, K. Kaiserova, J.M. Petrash, S.S. Chung, G. Hunt, B. Dawn, and A. Bhatnagar Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice Circ. Res. 105 2009 793 802
75. L.A. Suzuki, M. Poot, R.G. Gerrity, and K.E. Bornfeldt Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels Diabetes 50 2001 851 860 (Pubitemid 32242644)
76. J.D. Symons, S.L. McMillin, C. Riehle, J. Tanner, M. Palionyte, E. Hillas, D. Jones, R.C. Cooksey, M.J. Birnbaum, and D.A. McClain Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure Circ. Res. 104 2009 1085 1094
77. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat. Rev. Immunol. 10 2010 36 46
78. I. Tabas The role of endoplasmic reticulum stress in the progression of atherosclerosis Circ. Res. 107 2010 839 850
79. I. Tabas Pulling down the plug on atherosclerosis: finding the culprit in your heart Nat. Med. 17 2011 791 793
80. I. Tabas, and D. Ron Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress Nat. Cell Biol. 13 2011 184 190
81. I. Tabas, A.R. Tall, and D. Accili The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression Circ. Res. 106 2010 58 67
82. Y. Taniyama, H. Hitomi, A. Shah, R.W. Alexander, and K.K. Griendling Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II Arterioscler. Thromb. Vasc. Biol. 25 2005 1142 1147 (Pubitemid 40776600)
83. X. Tong, X. Hou, D. Jourd'heuil, R.M. Weisbrod, and R.A. Cohen Upregulation of Nox4 by TGFβ1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat Circ. Res. 107 2010 975 983
84. J.V. Valencia, M. Mone, C. Koehne, J. Rediske, and T.E. Hughes Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products Diabetologia 47 2004 844 852 (Pubitemid 38756997)
85. S. Vedantham, H. Noh, R. Ananthakrishnan, N. Son, K. Hallam, Y. Hu, S. Yu, X. Shen, R. Rosario, and Y. Lu Human aldose deductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice Arterioscler. Thromb. Vasc. Biol. 2011 10.1161/ATVBAHA.111.226902 in press. Published online June 2, 2011
86. L. Vergnes, J. Phan, M. Strauss, S. Tafuri, and K. Reue Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression J. Biol. Chem. 278 2003 42774 42784 (Pubitemid 37345887)
87. D. Vicent, J. Ilany, T. Kondo, K. Naruse, S.J. Fisher, Y.Y. Kisanuki, S. Bursell, M. Yanagisawa, G.L. King, and C.R. Kahn The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance J. Clin. Invest. 111 2003 1373 1380 (Pubitemid 36554708)
88. R.K. Vikramadithyan, Y. Hu, H.L. Noh, C.P. Liang, K. Hallam, A.R. Tall, R. Ramasamy, and I.J. Goldberg Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice J. Clin. Invest. 115 2005 2434 2443 (Pubitemid 41266205)
89. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Vulnerable plaque: the pathology of unstable coronary lesions J. Interv. Cardiol. 15 2002 439 446 (Pubitemid 35387383)
90. X. Wei, J.G. Schneider, S.M. Shenouda, A. Lee, D.A. Towler, M.V. Chakravarthy, J.A. Vita, and C.F. Semenkovich De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation J. Biol. Chem. 286 2011 2933 2945
91. Y. Wen, J. Gu, S.L. Li, M.A. Reddy, R. Natarajan, and J.L. Nadler Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages Endocrinology 147 2006 2518 2525
92. K.J. Williams, and E.A. Fisher Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr. Opin. Clin. Nutr. Metab. Care 8 2005 139 146
93. S.F. Yan, R. Ramasamy, and A.M. Schmidt The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Circ. Res. 106 2010 842 853